Study ID | Country | Study type | Subjects No. (Male, %) | Subject characteristics | Age, y | Follow-up, y | Donor cell line | Labeled-cholesterol | Cholesterol acceptor | NOS |
---|---|---|---|---|---|---|---|---|---|---|
Bauer, L, 2017 [30] | Germany | Cohort | 526 (59) | CKD | 65 ± 12 | 4.6 | J774 | 3H–cholesterol | ApoB-depleted plasma | 7 |
Tejera–Segura, B 2017 [31] | Spanish | Cross-sectional | 401 (26) | RA | 57 ± 10 | / | J774 | BODIPY-cholesterol | ApoB-depleted plasma | 5 |
Kopecky, C, 2016 [32] | German | Cohort | 1147 (54.8) | Hemodialysis patients | 66 | 4.1 | THP-1 | 3H–cholesterol | ApoB-depleted plasma | 7 |
Javaheri, A, 2016 [33] | USA | Cohort | 35 (85.7) | Cardiac transplant recipients | 44 ± 4 | 2.6 | J774 | 3H–cholesterol | ApoB-depleted plasma | 6 |
Mody, P, 2016 [34] | USA | Cohort | 1972 (44) | Free from CVD | 45 ± 9 | 9.4 | J774 | BODIPY-cholesterol | ApoB-depleted plasma | 8 |
Liu, C 2016 [35] | China | Cohort | 1737 (65.2) | CAD | 64 | 3.8 | J774 | BODIPY-cholesterol | ApoB-depleted plasma | 6 |
Zhang, J 2016 [36] | China | Cohort | 313 (75.4) | CAD | 66 ± 11 | 3 | J774 | 3H–cholesterol | ApoB-depleted plasma | 6 |
Ogura, M, 2016 [37] | Japan | Cross-sectional | 227 (44.5) | Heterozygous FH | 57 ± 17 | / | J774 | 3H–cholesterol | ApoB-depleted plasma | 6 |
Annema, W, 2016 [38] | Netherlands | Cohort | 495 (54.5) | Renal Transplant Recipients | 52 ± 12 | 7 | THP-1 | 3H–cholesterol | ApoB-depleted plasma | 8 |
Ishikawa, T, 2016 [39] | Japan | Case-control | 258 (76.7) | CAD VS non-CAD | 66 ± 11 | / | J774 | 3H–cholesterol | ApoB-depleted plasma | 5 |
Saleheen, D, 2015 [40] | UK | Nested case-control | 3494 (64.5) | CHD vs. non-CHD | 65 ± 8; | 6 | J774 | 3H–cholesterol | ApoB-depleted plasma | 8 |
Rohatgi, A, 2014 [12] | Dallas | Cohort | 2924 (43) | Free from CVD | 42 | 9.4 | J774 | BODIPY-cholestero | ApoB-depleted plasma | 9 |
Li, X M, 2013 [41] | USA | Case-control | 1150 (63.8) | CAD vs. non-CAD | 64 ± 11 | / | J774 | 3H–cholesterol | ApoB-depleted plasma | 6 |
Khera, A V1, 2011 [29] | Caucasian | Cross-sectional | 793 (59.7) | CAD vs. non-CAD | 58 ± 10 | / | J774 | 3H–cholesterol | ApoB-depleted plasma | 6 |
Khera, A V, 2011 [29] | Caucasian | Cross-sectional | 203 (54.2) | Healthy population | 51 ± 8 | / | J774 | 3H–cholesterol | ApoB-depleted plasma | 6 |